Panagora Asset Management Inc Ovid Therapeutics Inc. Transaction History

Panagora Asset Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 10, 2021	SELL	$3.31 - $4.04 $5,405 - $6,597	-1,633 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$3.3 - $4.49 $455 - $619	-138 Reduced 7.79%	1,633 $6,000
Q4 2020 Feb 10, 2021	BUY	$2.28 - $6.84 $4,037 - $12,113	1,771 New	1,771 $4,000
Q1 2018 May 15, 2018	SELL	$6.53 - $9.82 $65,371 - $98,308	-10,011 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$6.12 - $12.31 $61,267 - $123,235	10,011	10,011 $99,000

39M

37.4K

500

Ticker OVID
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,419,400
Market Cap $73.2M
Description
Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment o...

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Panagora Asset Management Inc with notifications on news.